Analystreport

Capricor Therapeutics Inc (NASDAQ: CAPR) had its price target raised by analysts at Maxim Group from $12.00 to $25.00. They now have a "buy" rating on the stock.

Capricor Therapeutics, Inc.  (CAPR) 
Last capricor therapeutics, inc. earnings: 3/18 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: capricor.com/investors